PhRMA hosts online and in-person events exploring science and policy issues that impact biopharmaceutical innovation and patient access to medicines. With members from the nation’s leading biopharmaceutical research companies, our events offer unique insights about the future of health in America.
Axios hosted a virtual event on the COVID-19 vaccine rollout. Axios co-founder Mike Allen and health care reporter Caitlin Owens unpacked the unprecedented COVID-19 vaccine development process as well as the road ahead, featuring NIAID Director Anthony Fauci and Pfizer chairman & CEO Albert Bourla.
Black and Brown Americans have been disproportionately impacted by the COVID-19 pandemic, experiencing a significant share of the devastating health and economic impact of the virus. While vaccines are critical to saving lives and getting the country back to normal, many individuals have questions about getting vaccinated. Black and Brown Americans in particular have important questions and seek to understand how the vaccines were developed and ensuring their safety and efficacy.
PhRMA sponsored the Washington Post Live event: The Lessons of a Pandemic. The event was hosted by Paige Winfield Cunningham, and focused on various lessons learned over the course of the COVID-19 pandemic. Those lessons included vaccinating children, vaccine research and hesitancy, new CDC guidance, and the biopharmaceutical industry’s work to combat the pandemic.
On July 9, 2020, The Hill gathered public health officials, policymakers and leaders from across the healthcare ecosystem to dive into the biggest medical and healthcare trends and innovations, considering both longitudinal trends and their interplay with the recent global health pandemic.